Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDK gel with ropivacaine for postoperative incision pain control after thoracoscopic and laparoscopic surgery
KCT0006079Phase 3Completed
- Sponsor
- Genewel
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in postoperative pain, pulmonary diseases, esophageal disease, None, sponsored by Genewel. Started May 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative painpulmonary diseasesesophageal disease
Beyond the preview
Go deeper on KCT0006079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006079.